Log In
Print
BCIQ
Print
Print this Print this
 

ALN-TMP

  Manage Alerts
Collapse Summary General Information
Company Alnylam Pharmaceuticals Inc.
DescriptionRNAi targeting transmembrane protease serine 6 (TMPRSS6; Matriptase-2)
Molecular Target Transmembrane protease serine 6 (TMPRSS6) (Matriptase-2)
Mechanism of ActionGene silencing
Therapeutic ModalityNucleic acid: Linear RNA
Latest Stage of DevelopmentPreclinical
Standard IndicationThalassemia
Indication DetailsTreat beta-thalassemia; Treat iron overload disorders
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today